Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) SVP Emily Dreyer sold 14,025 shares of the business’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $32.41, for a total transaction of $454,550.25. Following the completion of the transaction, the senior vice president now owns 27,645 shares in the company, valued at approximately $895,974.45. The trade was a 33.66 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Trupanion Stock Up 2.3 %
Shares of TRUP stock traded up $0.74 on Tuesday, reaching $33.20. 586,401 shares of the company were exchanged, compared to its average volume of 641,189. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The company has a 50-day moving average of $43.80 and a 200-day moving average of $47.42. The company has a market cap of $1.41 billion, a price-to-earnings ratio of -144.35, a PEG ratio of 6.02 and a beta of 1.70. Trupanion, Inc. has a one year low of $19.69 and a one year high of $57.90.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02). The firm had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. Analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on TRUP shares. Piper Sandler lowered their price objective on Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Stifel Nicolaus lowered their target price on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $46.60.
Check Out Our Latest Report on TRUP
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- Differences Between Momentum Investing and Long Term Investing
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Golden Cross Stocks: Pattern, Examples and Charts
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Overbought Stocks Explained: Should You Trade Them?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.